[Billing Code: 4140-01-P]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby
given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions
could disclose confidential trade secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special Emphasis Panel NIDA-K
Alternate SEP
Date: August 1, 2024
Time: 12:00 PM to 12:45 PM
Agenda: To review and evaluate grant applications
Place: National Institute of Health
National Institute on Drug Abuse
301 North Stonestreet Avenue
Bethesda, MD 20892
Contact Person: Marisa Srivareerat, Ph.D.
Scientific Review Officer
Scientific Review Branch
Office of Extramural Policy
National Institute on Drug Abuse, NIH
301 North Stonestreet Avenue, MSC 6021

Bethesda, MD 20892
(301) 435-1258
marisa.srivareerat@nih.gov
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279,
Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS)
Dated: July 2, 2024.
Lauren A. Fleck,
Program Analyst,
Office of Federal Advisory Committee Policy.
[FR Doc. 2024-14870 Filed: 7/5/2024 8:45 am; Publication Date: 7/8/2024]